> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Authorizes First Home Collection Covid Test
- URL: https://www.fdaweb.com/fda-authorizes-first-home-collection-covid-test/
- Published: 2020-04-21T12:00:00.000Z
- Updated: 2026-09-14T16:12:04.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5146613

FDA has authorized the Laboratory Corporation of America (LabCorp) Covid-19 RT-PCR test to permit testing of samples self-collected by patients at home using the company’s Pixel home collection test kit. The agency reissued an emergency use authorization for the test, the first such test with a home collection option, according to an FDA [statement](https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-test-patient-home-sample-collection?ref=fdaweb.com).

The statement says the reissued authorization permits testing of a sample collected from a patient’s nose using a designated self-collection kit that contains nasal swabs and saline. Once patients self-swab to collect their nasal sample, FDA says, they mail the sample in an insulated package to a LabCorp lab for testing. The company says it plans to make the kits available to consumers in most states with a doctor’s order in the coming weeks.

“This authorization only applies to the LabCorp Covid-19 RT-PCR test for at-home collection of nasal swab specimens using the Pixel by LabCorp Covid-19 home collection kit,” FDA says. “It is important to note that this is not a general authorization for at-home collection of patient samples using other collection swabs, media, or tests, or for tests fully conducted at home.”